These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8459811)

  • 1. [Secondary myocardial hypertrophy in a very small premature infant treated with dexamethasone].
    Korsch E; Gillor A; Groneck P; Bläker F
    Monatsschr Kinderheilkd; 1993 Feb; 141(2):112-5. PubMed ID: 8459811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia.
    Werner JC; Sicard RE; Hansen TW; Solomon E; Cowett RM; Oh W
    J Pediatr; 1992 Feb; 120(2 Pt 1):286-91. PubMed ID: 1735831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible steroid-induced hypertrophic cardiomyopathy with left ventricular outflow tract obstruction in two newborns.
    Haney I; Lachance C; van Doesburg NH; Fouron JC
    Am J Perinatol; 1995 Jul; 12(4):271-4. PubMed ID: 7575834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of beta-blockade on symptomatic dexamethasone-induced hypertrophic obstructive cardiomyopathy in premature infants: three case reports and literature review.
    Fritz KI; Bhat AM
    J Perinatol; 1998; 18(1):38-44. PubMed ID: 9527943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophic cardiomyopathy in preterm infants treated with methylprednisolone for bronchopulmonary dysplasia.
    Dani C; Bertini G; Simone P; Rubaltelli FF
    Pediatrics; 2006 May; 117(5):1866-7. PubMed ID: 16651362
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac effects of dexamethasone in very low birth weight infants.
    Bensky AS; Kothadia JM; Covitz W
    Pediatrics; 1996 Jun; 97(6 Pt 1):818-21. PubMed ID: 8657520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertrophic cardiomyopathy associated with dexamethasone therapy for chronic lung disease in preterm infants.
    Israel BA; Sherman FS; Guthrie RD
    Am J Perinatol; 1993 Jul; 10(4):307-10. PubMed ID: 8397569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac adverse effects of early dexamethasone treatment in preterm infants: a randomized clinical trial.
    Zecca E; Papacci P; Maggio L; Gallini F; Elia S; De Rosa G; Romagnoli C
    J Clin Pharmacol; 2001 Oct; 41(10):1075-81. PubMed ID: 11583475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertrophic obstructive cardiomyopathy as a side effect of dexamethasone treatment for bronchopulmonary dysplasia.
    Brand PL; van Lingen RA; Brus F; Talsma MD; Elzenga NJ
    Acta Paediatr; 1993; 82(6-7):614-7. PubMed ID: 8339005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transient hypertrophic cardiomyopathy due to dexamethasone therapy in a premature infant].
    Pokela ML
    Duodecim; 1995; 111(14):1310-3. PubMed ID: 9244681
    [No Abstract]   [Full Text] [Related]  

  • 11. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
    Ballabh P; Simm M; Kumari J; Califano C; Aghai Z; Laborada G; Sison C; Cunningham-Rundles S
    Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone given to premature infants and cardiac diastolic function in early childhood.
    Wong IH; Digby AM; Warren AE; Pepelassis D; Vincer M; Chen RP
    J Pediatr; 2011 Aug; 159(2):227-31. PubMed ID: 21397911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transient hypertrophic neonatal myocardiopathy after acute fetal distress].
    Guimarães P; Teixeira F; Morais L; Alvares S
    Rev Port Cardiol; 1998 Jan; 17(1):89-92. PubMed ID: 9580509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertrophic cardiomyopathy in a low-birth-weight newborn treated with dexamethasone].
    Villa Alcázar M; Pellicer Martínez A; Burgueros Valero M; Quero Jiménez J
    An Esp Pediatr; 1996 Apr; 44(4):393-4. PubMed ID: 8796947
    [No Abstract]   [Full Text] [Related]  

  • 15. [Glucocorticoid-induced hypertrophic cardiomyopathy in premature infants: apropos of 4 cases].
    Boeuf B; Maragnes P; Belzic I; Lacotte J; Bonte JB; Guillois B
    Arch Pediatr; 1997 Feb; 4(2):152-7. PubMed ID: 9097827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrophic Cardiomyopathy After a Single Dose of Dexamethasone in a Preterm Infant.
    Kale Y; Aydemir O; Ceylan O; Bas AY; Demirel N
    Pediatr Neonatol; 2015 Aug; 56(4):268-70. PubMed ID: 23639746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible obstructive hypertrophic cardiomyopathy after dexamethasone therapy for bronchopulmonary dysplasia.
    Ohning BL; Fyfe DA; Riedel PA
    Am Heart J; 1993 Jan; 125(1):253-6. PubMed ID: 8417533
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in neonatology: comparison of two cohorts of very preterm infants (gestational age <32 weeks): the Project On Preterm and Small for Gestational Age Infants 1983 and the Leiden Follow-Up Project on Prematurity 1996-1997.
    Stoelhorst GM; Rijken M; Martens SE; Brand R; den Ouden AL; Wit JM; Veen S;
    Pediatrics; 2005 Feb; 115(2):396-405. PubMed ID: 15689337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic cardiomyopathy in preterm infants treated with dexamethasone.
    Miranda-Mallea J; Pérez-Verdú J; Gascó-Lacalle B; Sáez-Palacios JM; Fernández-Gilino C; Izquierdo-Macián I
    Eur J Pediatr; 1997 May; 156(5):394-6. PubMed ID: 9177985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
    McEvoy C; Bowling S; Williamson K; McGaw P; Durand M
    Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.